B2DB — Who said what, where, and when

Marco Prado

The University of Western Ontario

Marco Prado is listed as The University of Western Ontario. Marco is scheduled to speak at AD/PD 2027 – Advances in Science & Therapy on 17 March 2027.

Compiled from published conference agendas; not yet confirmed by Marco. Is this you? Claim this profile.

About

Marco A. M. Prado, Pharm., M.Sc. and Ph.D. is the Tier 1 CRC in Neurochemistry of Dementia at the University of Western Ontario. Dr. Prado focus is on understanding how neurochemical alterations in neurodegenerative diseases contribute to protein misfolding and cognitive dysfunction. He combines innovative mouse models of disease with the use of sophisticated touchscreen tests of high-level cognition and detailed biochemical, imaging, and genetic analysis. This high-throughput cognitive approach allows for testing up to 700 mice daily. His goal is to help improve predictive validity using mouse models of neurodegenerative diseases to accelerate outcomes in clinical trials with new effective therapeutics. Dr. Prado is currently spearheading with several colleagues an Open Science Repository (www.mousebytes.ca) for high-level cognitive data in mouse models of dementia.

Upcoming

AD/PD 2027 – Advances in Science & Therapy 16 March 2027 – 20 March 2027